Edo Agustian Indonesian Drug Users Network kornas@pkni

1. Hepatitis C among people who inject drugs in Indonesia : An urgent public health crisis • Edo Agustian • Indonesian Drug Users Network • kornas@pkni.org • HCV and PWID in Asia Strategies for Treatment Scale up

2. Outline of Presentation • Overview of hepatitis C among people who inject drugs in Indonesia • Indonesia’s national response • Barriers to testing and treatment access • Advocacy and community engagement

3. Viral Hepatitis in Indonesia

4. The national response to the prevention, treatment and management ofhepatitis C among people who inject drugs • Late response, fragmented • Indonesia does not conduct routine national surveillance • There is no national clinical guideline for diagnosis, treatment and care for HCV • The Ministry of Health first established a national program focused on viral hepatitis in 2011, under the Sub Directorate for Gastrointestinal Infections and Diarrheal Diseases.

6. Monitoring of the quality of harm reduction programs in 9 provinces by the drug user community

10. Advocacy and community engagement Since 2011, PKNI has worked with drug users, policy-makers, and service providers to raise awareness about Hep C and ensure that the community is meaningfully involved in the national response. Highlights include: • Fill pre grant opposition against Sofosbufir patent registration • Training of service providers across 9 provinces • Collaboration with Indonesian Liver Researchers Association and Ministry of health on public Hep C campaign • Policy briefing on Hep C • Hepatitis C Community Task Force to input in MoH planning • Treatment price reductions and pharma advocacy • Involved in developing National Guideline for Hep C Care, Support and Treatment with MoH in 2014